Cover Image
市場調查報告書

肱骨外上髁炎(網球肘):開發中產品分析

Lateral Epicondylitis(Tennis Elbow) - Pipeline Review, H1 2015

出版商 Global Markets Direct 商品編碼 302495
出版日期 內容資訊 英文 39 Pages
訂單完成後即時交付
價格
Back to Top
肱骨外上髁炎(網球肘):開發中產品分析 Lateral Epicondylitis(Tennis Elbow) - Pipeline Review, H1 2015
出版日期: 2015年03月19日 內容資訊: 英文 39 Pages
簡介

肱骨外上髁炎(網球肘)是肌腱炎的一種,會引起手肘及手腕疼痛。高齡化、打網球、壁球或舉重等運動,是得到該疾病的主要原因。

本報告提供肱骨外上髁炎(網球肘)治療藥的開發情形相關調查,提供開發中產品的概要,臨床實驗各階段的產品概要,再加上主要企業簡介,藥物簡介,開發中產品的最新趨勢等。

簡介

  • 調查範圍

肱骨外上髁炎(網球肘)概要

治療藥的開發

  • 開發中產品的概要
  • 開發中產品比較分析

肱骨外上髁炎(網球肘):企業開發中的治療藥

肱骨外上髁炎(網球肘):開發中產品概況

  • 後期階段的產品
  • 臨床階段的產品

肱骨外上髁炎(網球肘):企業開發中的產品

肱骨外上髁炎(網球肘)的治療藥開發企業

  • 生化學工業
  • Chugai Pharmaceutical Co., Ltd.
  • Teikoku Pharma USA, Inc.
  • Molecular Pharmacology (USA) Limited
  • Kasiak Research Pvt. Ltd.

肱骨外上髁炎(網球肘):治療藥的評估

  • 單劑產品
  • 標的別
  • 各作用機制
  • 各給藥途徑
  • 各類型分子

藥物簡介

  • 玻尿酸鈉
  • TPW-182
  • Refaheal
  • RCT-01
  • MPLTL-100

肱骨外上髁炎(網球肘):最近的開發平台趨勢

肱骨外上髁炎(網球肘):暫停中的計劃

肱骨外上髁炎(網球肘):產品開發的里程碑

  • 主要消息和新聞稿

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC6445IDB

Summary

Global Markets Direct's, 'Lateral Epicondylitis(Tennis Elbow) - Pipeline Review, H1 2015', provides an overview of the Lateral Epicondylitis(Tennis Elbow)'s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Lateral Epicondylitis(Tennis Elbow), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Lateral Epicondylitis(Tennis Elbow) and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Lateral Epicondylitis(Tennis Elbow)
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Lateral Epicondylitis(Tennis Elbow) and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Lateral Epicondylitis(Tennis Elbow) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Lateral Epicondylitis(Tennis Elbow) pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Lateral Epicondylitis(Tennis Elbow)
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Lateral Epicondylitis(Tennis Elbow) pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
    • Lateral Epicondylitis(Tennis Elbow) Overview
  • Therapeutics Development
    • Pipeline Products for Lateral Epicondylitis(Tennis Elbow) - Overview
    • Pipeline Products for Lateral Epicondylitis(Tennis Elbow) - Comparative Analysis
  • Lateral Epicondylitis(Tennis Elbow) - Therapeutics under Development by Companies
  • Lateral Epicondylitis(Tennis Elbow) - Pipeline Products Glance
    • Late Stage Products
    • Clinical Stage Products
  • Lateral Epicondylitis(Tennis Elbow) - Products under Development by Companies
  • Lateral Epicondylitis(Tennis Elbow) - Companies Involved in Therapeutics Development
    • Kasiak Research Pvt. Ltd.
    • Molecular Pharmacology (USA) Limited
    • RepliCel Life Sciences, Inc.
    • Seikagaku Corporation
    • Teikoku Pharma USA, Inc.
  • Lateral Epicondylitis(Tennis Elbow) - Therapeutics Assessment
    • Assessment by Monotherapy Products
    • Assessment by Target
    • Assessment by Mechanism of Action
    • Assessment by Route of Administration
    • Assessment by Molecule Type
  • Drug Profiles
    • ALLO-ASC - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • hyaluronate sodium - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MPLTL-100 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • RCT-01 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Refaheal - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TPW-182 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Lateral Epicondylitis (Tennis Elbow) - Recent Pipeline Updates
  • Lateral Epicondylitis(Tennis Elbow) - Dormant Projects
  • Lateral Epicondylitis(Tennis Elbow) - Discontinued Products
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Number of Products under Development for Lateral Epicondylitis(Tennis Elbow), H1 2015
  • Number of Products under Development for Lateral Epicondylitis(Tennis Elbow) - Comparative Analysis, H1 2015
  • Number of Products under Development by Companies, H1 2015
  • Comparative Analysis by Late Stage Development, H1 2015
  • Comparative Analysis by Clinical Stage Development, H1 2015
  • Products under Development by Companies, H1 2015
  • Lateral Epicondylitis(Tennis Elbow) - Pipeline by Kasiak Research Pvt. Ltd., H1 2015
  • Lateral Epicondylitis(Tennis Elbow) - Pipeline by Molecular Pharmacology (USA) Limited, H1 2015
  • Lateral Epicondylitis(Tennis Elbow) - Pipeline by RepliCel Life Sciences, Inc., H1 2015
  • Lateral Epicondylitis(Tennis Elbow) - Pipeline by Seikagaku Corporation, H1 2015
  • Lateral Epicondylitis(Tennis Elbow) - Pipeline by Teikoku Pharma USA, Inc., H1 2015
  • Assessment by Monotherapy Products, H1 2015
  • Number of Products by Stage and Target, H1 2015
  • Number of Products by Stage and Mechanism of Action, H1 2015
  • Number of Products by Stage and Route of Administration, H1 2015
  • Number of Products by Stage and Molecule Type, H1 2015
  • Lateral Epicondylitis(Tennis Elbow) Therapeutics - Recent Pipeline Updates, H1 2015
  • Lateral Epicondylitis(Tennis Elbow) - Dormant Projects, H1 2015
  • Lateral Epicondylitis(Tennis Elbow) - Discontinued Products, H1 2015

List of Figures

  • Number of Products under Development for Lateral Epicondylitis(Tennis Elbow), H1 2015
  • Number of Products under Development for Lateral Epicondylitis(Tennis Elbow) - Comparative Analysis, H1 2015
  • Number of Products under Development by Companies, H1 2015
  • Comparative Analysis by Clinical Stage Development, H1 2015
  • Assessment by Monotherapy Products, H1 2015
  • Number of Products by Top 10 Targets, H1 2015
  • Number of Products by Stage and Top 10 Targets, H1 2015
  • Number of Products by Top 10 Mechanism of Actions, H1 2015
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
  • Number of Products by Top 10 Routes of Administration, H1 2015
  • Number of Products by Stage and Top 10 Routes of Administration, H1 2015
  • Number of Products by Top 10 Molecule Types, H1 2015
  • Number of Products by Stage and Top 10 Molecule Types, H1 2015
Back to Top